Shanghai Genon Bioengineering Co.

Shanghai, China

Shanghai Genon Bioengineering Co.

Shanghai, China

Time filter

Source Type

Lan C.,Sichuan Agricultural University | Lan C.,Shanghai Genon Bioengineering Co. | Ren L.,Shanghai Genon Bioengineering Co. | Wu M.,Sichuan Agricultural University | And 7 more authors.
Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology | Year: 2013

In producing transgenic livestock, selectable marker genes (SMGs) are usually used to screen transgenic cells from numerous normal cells. That results in SMGs integrating into the genome and transmitting to offspring. In fact, SMGs could dramatically affect gene regulation at integration sites and also make the safety evaluation of transgenic animals complicated. In order to determine the deletion time and methods in the process of producing transgenic goats, the feasibility of deleting SMGs was explored by Cre/LoxP before or after somatic cell cloning. In addition, we compared the efficiency of protein transduction with plasmids co-transduction. We could delete 43.9% SMGs after screening out the transgenic cell clones, but these cells could not be applied to somatic cells cloning because of serious aging after two gene modifications. The SMG-free cells suitable for nuclear transfer were accessible by using the cells of transgenic goats, but this approach was more time consuming. Finally, we found that the Cre plasmid could delete SMGs with an efficiency of 7.81%, but about 30% in SMG-free cells had sequences of Cre plasmid. Compared with Cre plasmid, the integration of new exogenous gene could be avoided by TAT-CRE protein transduction, and the deletion rate of TAT-CRE transduction was between 43.9 and 72.8%. Therefore, TAT-Cre transduction could be an effective method for deleting selectable marker genes.


Patent
Shanghai Genon Bioengineering Co. and Shanghai Transgenic Research Center | Date: 2016-08-03

Provided in the present invention is a method for positioning and integrating transgene and a use thereof. Specifically provided is a variant loxP element. The sequence ATAAT of an reverse repeated sequence in a wild type loxp locus is mutated into CACCT, i.e., a variant loxp element. Also provided in the present invention are a construct comprising the variant loxP element, a vector or host cell comprising the construct and a method for preparing a transgenic animal using the vector and the host cell.


Patent
Shanghai Genon Bioengineering Co. and Shanghai Transgenic Research Center | Date: 2013-09-28

Provided in the present invention is a method for positioning and integrating transgene and a use thereof. Specifically provided is a variant loxP element. The sequence ATAAT of an reverse repeated sequence in a wild type loxp locus is mutated into CACCT, i.e., a variant loxp element. Also provided in the present invention are a construct comprising the variant loxP element, a vector or host cell comprising the construct and a method for preparing a transgenic animal using the vector and the host cell.

Loading Shanghai Genon Bioengineering Co. collaborators
Loading Shanghai Genon Bioengineering Co. collaborators